Keynote Presenters

Jon Meacham, Pulitzer Prize-Winning Author and Presidential Historian
Mr. Meacham, executive vice president and executive editor at Random House, will talk about "Lessons from American Presidencies – The Art of Leadership." His latest book is “Destiny and Power,” a biography of President George H.W. Bush. “Thomas Jefferson: The Art of Power” is among his New York Times bestsellers. Mr. Meacham regularly appears on “Morning Joe,” “Meet the Press” and other broadcasts.

Stephen K. Klasko, MD, MBA, President and CEO, Thomas Jefferson University and Jefferson Health
Dr. Klasko is an obstetrician, CEO and author. His latest book is “We CAN Fix Healthcare – The Future is Now.” He is an international keynote speaker, sharing his optimistic view of health care. Since 2014, Jefferson Health has grown from a $1.8 billion enterprise with three hospitals to a nearly $3.4 billion geographically dispersed regional academic medical center with eight hospitals.

James P. Kiley, BS, MS, PhD, Director of the Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH)
Before joining the Division of Lung Diseases, Dr. Kiley was Director of the NIH National Center on Sleep Disorders Research. He belongs to several professional organizations and has received numerous awards for his contributions to advancing pulmonary biology in health and disease, sleep research, and public health. His interests include respiration control and obstructive airways disease. Dr. Kiley is the author or co-author of over 100 scientific articles.

Anne Schuchat, MD (RADM, USPHS), Principal Deputy Director, Centers for Disease Control and Prevention (CDC), and Rear Admiral of the U.S. Public Health Service
Dr. Schuchat began her public health career in 1988 when she came to CDC as an Epidemic Intelligence Service Officer. She was director of CDC's National Center for Immunization and Respiratory Diseases from 2006 to 2015. Other CDC leadership posts include acting director of the National Center for Infectious Diseases and the Center for Global Health; chief of the Respiratory Diseases Branch and chief health officer for CDC's 2009 H1N1 pandemic influenza response. Globally, Dr. Schuchat has worked in West Africa on meningitis, pneumonia and Ebola vaccine trials, in South Africa on surveillance and prevention projects, and in China on Beijing's SARS emergency response. She has authored or co-authored more than 230 scientific articles, book chapters and reviews.

Chris Wilson, MD, Director of Global Health Discovery and Translational Science, Bill & Melinda Gates Foundation
Dr. Wilson, a pediatrician and immunologist, led a team at the Gates Foundation that targets fundamental scientific and technological advances in global health that create new prevention, treatment and diagnostic techniques. He has also served on a number of national advisory panels, including the Institute of Medicine Vaccine Safety Review Committee.

Brian Day, PhD, Vice Chair of Research, Medicine Office of Research, National Jewish Health
Dr. Day, a professor in the National Jewish Health Department of Medicine, is responsible for overseeing research at the institution. His interests include cystic fibrosis, COPD, interstitial lung disease and drug development. He has been awarded grant support from the National Institutes of Health, the Cystic Fibrosis Foundation and others. He also holds 19 patents in oxidant biology and has been published more than 130 times.

 

Distinguished Panelists

John J. Reilly Jr., MD, Dean, University of Colorado School of Medicine
Dr. Reilly joined the University of Colorado in April 2015 from the University of Pittsburgh, where he was Chair of the Department of Medicine. He also spent over 20 years at Boston’s Brigham and Women’s Hospital. He has authored or co-authored more than 100 peer-reviewed research reports. His interests include COPD, emphysema and lung cancer.

Donna Lynne, DrPH, Colorado Lieutenant Governor
Dr. Lynne was recently confirmed as the lieutenant governor of Colorado. Previously, she was executive vice president of Kaiser Foundation Hospitals and Health Plan, Inc. There, she was responsible for Kaiser Permanente’s Colorado, Hawaii and Northwest regions. In Colorado, Kaiser is the state’s largest group medical practice organization.

Michael (Mike) Slubowski, FACHE, FACMPE, President and CEO, SCL Health
Mr. Slubowski provides executive leadership to SCL Health’s health care ministry of 10 hospitals, more than 160 physician clinics, home health care, hospice and other health care services in Colorado, Kansas and Montana. He is also a member of the National Jewish Health Board of Directors.

Gregory Downey, MD, Executive Vice President, Academic Affairs, National Jewish Health
Dr. Downey oversees academic and research programs at National Jewish Health and is responsible for integrating the clinical and research efforts of the Departments of Medicine, Pediatrics, Biomedical Research and Radiology. He is largely responsible for the vision behind The Institute for Lung Health, which will lead the world in integrating basic, translational and clinical research for lung and immune diseases.